These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3312502)

  • 1. Labetalol compared with propranolol in the treatment of black hypertensive patients.
    Saunders E; Curry C; Hinds J; Kong BW; Medakovic M; Poland M; Roper K
    J Clin Hypertens; 1987 Sep; 3(3):294-302. PubMed ID: 3312502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy with labetalol compared with propranolol. Differential effects by race.
    Flamenbaum W; Weber MA; McMahon FG; Materson BJ; Carr AA; Poland M
    J Clin Hypertens; 1985 Mar; 1(1):56-69. PubMed ID: 3915317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
    J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Kochar MS; Tyson J; Kalbfleisch JH
    J Clin Pharmacol; 1985 Sep; 25(6):433-6. PubMed ID: 3902912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
    Oster G; Huse DM; Delea TE; Savage DD; Colditz GA
    J Natl Med Assoc; 1987 Oct; 79(10):1049-55. PubMed ID: 3119865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol.
    Falliers CJ; Vrchota J; Blasucci DJ; Maloy JW; Medakovic M
    J Clin Hypertens; 1985 Mar; 1(1):70-9. PubMed ID: 3836297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol as monotherapy in hypertensive black patients.
    Cubberley RB
    J Clin Hypertens; 1985 Dec; 1(4):304-14. PubMed ID: 2873208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA; Frishman WH; Wallin JD; Gorwit J; Davidov ME; Michelson EL; Bedsole GD; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):45I-49I. PubMed ID: 2658529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
    Kubik MM; Coote JH
    Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN; Bauer GE; Ross M; Larkin H
    Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
    Bennett JM; Weich DJ; Schoeman HS
    S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.